576 related articles for article (PubMed ID: 32498097)
1. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
Langer F; Kluge S; Klamroth R; Oldenburg J
Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
3. [Coagulopathy and COVID-19. Recommendations for a changing reality].
Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
[TBL] [Abstract][Full Text] [Related]
4. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
Aryal MR; Gosain R; Donato A; Pathak R; Bhatt VR; Katel A; Kouides P
Curr Cardiol Rep; 2020 Jun; 22(7):52. PubMed ID: 32529517
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated coagulopathy.
Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
7. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
Tal S; Spectre G; Kornowski R; Perl L
Acta Haematol; 2020; 143(5):417-424. PubMed ID: 32396903
[TBL] [Abstract][Full Text] [Related]
9. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
Pooni RS
Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
[No Abstract] [Full Text] [Related]
10. The management of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC
Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
[TBL] [Abstract][Full Text] [Related]
11. Focus on coronavirus disease 2019 associated coagulopathy.
Yang XH; Li RR; Sun RH; Liu J; Chen DC
Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
[No Abstract] [Full Text] [Related]
12. COVID-19, coagulopathy and venous thromboembolism: more questions than answers.
Marietta M; Coluccio V; Luppi M
Intern Emerg Med; 2020 Nov; 15(8):1375-1387. PubMed ID: 32653981
[TBL] [Abstract][Full Text] [Related]
13. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
[TBL] [Abstract][Full Text] [Related]
15. Hematological findings and complications of COVID-19.
Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
17. Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.
Godoy LC; Goligher EC; Lawler PR; Slutsky AS; Zarychanski R
CMAJ; 2020 Oct; 192(40):E1156-E1161. PubMed ID: 32816822
[No Abstract] [Full Text] [Related]
18. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
Haimei MA
Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
Ahmed SI; Khan S
Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
[TBL] [Abstract][Full Text] [Related]
20. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection.
Llau JV; Ferrandis R; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A; Quintana M; Amezaga R; Gero M; Serrano A; Marcos P
Rev Esp Anestesiol Reanim (Engl Ed); 2020; 67(7):391-399. PubMed ID: 32591185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]